スコッツ ミラクルグローに関するコメント

MAYDAY!!!
     🤣  hahaha, my favorite gif 🤣
🎵 Here's where the story ends
It's that little souvenir of a terrible year
Which makes my eyes feel sore
It's that little souvenir of a terrible year
Surprise, surprise, surprise 🎵
I'm going to try and get a post out. I'm really uncomfortable and sore, but there are some big moves and big news ahead.
A little Sundays to start the day
As I said, I'm fresh out of the hospital again. I've been oversleeping and much too tired 😫.  I feel gu...

Raymond James analyst attributes stock's performance to optimism in cannabis sector, potential interest rate cuts, and strong Q1 results. Notes potential regulatory changes in cannabis industry and future interest-rate cuts could benefit the company.

The declining trend in Scotts Miracle-Gro's ROCE and the flat capital employed suggest that the company may be facing competitive pressure and could be maturing. If these trends continue, the company's growth potential could be limited.

Scotts Miracle-Gro's consistent revenue and share price decline is worrisome for investors. Despite challenges, the company's ability to pay dividends has somewhat cushioned the blow on total shareholder return. Yet, unresolved challenges may continue to impact the stock's performance.

Significant insider selling at Scotts Miracle-Gro, including the President's 67% stake sale, may indicate insiders believe shares are overpriced. The absence of insider buying recently and low insider ownership could caution potential investors.

Scotts Miracle-Gro's P/S ratio is similar to the industry average despite the company's lower growth outlook. If this ratio aligns with the lower growth expectations, shareholder disappointment and share price dropdown may follow.

Scotts Miracle-Gro's stocks seem overvalued with future growth already reflected in current pricing. Analysts suggest potential investors wait for a price drop; current shareholders should ponder selling.